Eastern Europe: New OTC Market Studies

8 July 1997

- Nicholas Hall & Co's new OTC Market Guide: Central and Eastern Europeexamines these over-the-counter markets which are forecast to grow from $1.5 billion in 1995 to over $2 billion by 2000. The Guide contains comprehensive market facts, local company profiles and regional OTC marketing strategies.

Also from Nicholas Hall, OTC Opportunities in Emerging World Markets: Former Soviet Union gives data and analysis on Russia, Ukraine and the Baltics, plus summaries of developments in Belarus, Caucasus and Central Asia. Category analysis, market developments, regulatory issues, company profiles and market forecasts to 2006 are provided. For further details, in Europe phone: +44 1702 220200; fax: +44 1702 430787. Asia, phone: +65 392 2716; fax: +65 392 2715. Americas, phone: +1 215 540 4210; fax: +1 215 540 4209.

- James Dudley Management's new report, Self-medication in Central and Eastern Europe, examines the expansion of the Czech Republic, Hungary, Poland and Russia, which it says are Europe's most attractive new OTC markets.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight